##plugins.themes.academic_pro.article.sidebar##

Download
pdf
Statistic
Read Counter : 69 Download : 87

##plugins.themes.academic_pro.article.main##

Abstract

This article discusses the importance of endothelial dysfunction in patients with COVID-19 due to chronic heart failure and the effectiveness of its treatment.

Keywords

medicine heart failure COVID-19 patient endothelial dysfunction

##plugins.themes.academic_pro.article.details##

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

How to Cite
Narzullayev Hayotillo Fayzulla o`g`li, Gadaev A.G, Rahimova M.E, Tosharov F.Z, & Hamrayev S.R. (2022). Assessment of Endothelial Dysfunction in Patients with Covid-19 Based on Chronic Heart Failure and its Significance in the Effectiveness of the Treatment. Texas Journal of Medical Science, 15, 208–213. https://doi.org/10.62480/tjms.2022.vol15.pp208-213
Crossref
Scopus
Google Scholar
Europe PMC

References

  1. Alipio M. Vitamin D supplementation could possibly improve clinical outcomes of patients infected with coronavirus‐ 2019 (COVID‐ 19). Available at SSRN 3571484. 2020.
  2. Bai Y, Yao L, Wei T, Tian F, Jin DY, Chen L et al. Presumed Asymptomatic Carrier Transmission of COVID-19. JAMA 2020 Feb 21
  3. Baqui A.H., Black R.E., Arifeen S., et al. Causes of childhood deaths in Bangladesh: results of a nationwide verbal autopsy study. Bull World Health Organ. 2018; 76(2): 161.
  4. Barlow A., landolf K.M., Barlow B, Yeung SYA, Heavner JJ, Claassen CW et al. Review of Emerging Pharmacotherapy for the Treatment of Coronavirus Disease 2019. Pharmacotherapy, 2020 Apr 2017
  5. Barron E, Bakhai C, Kar P, Weaver A, Bradley D, Ismail H et al. Assotiation of type 1 and type 2 diabetes with COVID-19 related mortality in England: a whole-population study. Lancet Diabetes Endocrinol. 2020 Aug 13 м
  6. Bialek Stephanie, Gierke Ryan, Hughes Michelle, McNamara LucyA. Coronavirus disease 2019 in children — United States, February 12– April 2, 2020. Morb Mortal Wkly Rep. 2020; 69(14): 422‐ 426.
  7. CDC. Coronavirus Disease 2019 (COVID-19): Recommendations for Clith Face Covers. Center for Disease Control and Prevention. April 3, 2020
  8. Giannis D., Ziogas I.A., Gianni P. Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past. J. Clin. Virol. 2020; 127.
  9. Guo L, Rondina MT. The Era of Thromboinflammation: Platelets Are Dynamic Sensors and Effector Cells During Infectious Diseases. Front Immunol. 2019; 10: 2204. Published 2019 Sep 13
  10. Guzik T.J., Harrison D.G. Vascular NADPH oxidases as drug targets for novel antioxidant strategies. Drug Discovery Today. 2006;11- 12:524-526.
  11. Han H, Yang L, Liu R, et al. Prominent changes in blood coagulation of patients with SARS-CoV- 2 infection. Clin Chem Lab Med. 2020.
  12. Higashi Y., Noma K., Yoshizumi M., Kihara Y. Endothelial function and oxidative stress in cardiovascular diseases. Circulation J. 2009; 3:411-415.
  13. Levi M. COVID-19 coagulopathy vs disseminated intravascular coagulation. Blood Adv. 2020; 4(12).
  14. Lillicrap D. Disseminated intravascular coagulation in patients with 2019-nCoV pneumonia. J Thromb Haemost. 2020; 18(4):786- 787.Stagi S, Rigante D, Lepri G, Matucci Cerinic M, Falcini F. Severe vitamin D deficiency in patients with Kawasaki disease: a potential role in the risk to develop heart vascular abnormalities? Clin Rheumatol. 2016; 35(7): 1865‐ 1872.
  15. Bobkova IN, Chebotareva IV, Rameev VV, Plieva OK, Kozlovskaya LV. The role of endothelial dysfunction in the progression of glomerulonephritis, modern possibilities for its correction. Therapeutic archive. 2005; 77 (6): 92- 96.
  16. Galenko A.S., Shulenin S.N. Methods for nondrug and pharmacological correction of endothelial dysfunction. PHARMindeks- Practitioner. 2006; issue 10: 2-10.
  17. Endothelial dysfunction. Causes, mechanisms, pharmacological correction. Ed. Petrishcheva N.N. St. Petersburg: Publishing house of St. Petersburg State Medical University; 2003.
  18. Dremina N.N., Shurygin M.G., Shurygina I.A. Endothelin in norm and pathology. International Journal of Applied and Basic Research. 2016; 10 (2): 210-214.
  19. Martynov A.I., Avetyak N.G., Akatova E.V., Gorokhovskaya T.N., Romanovskaya G.A. Endothelial dysfunction and methods of its definition. Russian medical journal. 2005; 10 (4): 94-98.
  20. Mayanskaya S.D., Antonov A.R., Popova A.A., Grebenkina I.A. Early markers of endothelial dysfunction in the dynamics of the development of arterial hypertension in young people. Kazan Medical Journal. 2009; 90 (1): 32-37.
  21. Melnikova Yu.S., Makarova T.P. Endothelial dysfunction as a central link in the pathogenesis of chronic diseases. Kazan Medical Journal. 2015; 96 (4): 659-665.
  22. Panina I.Yu., Rumyantsev A.Sh., Menshutina M.A., Achkasova V.V., Degtereva O.A., Tugusheva F.F., Zubina I.M. Features of endothelial function in chronic kidney disease. Literature review and own data. Nephrology. 2007; 11 (4): 28-46.
  23. Putilina MV The role of endothelial dysfunction in cerebrovascular diseases. Doctor; 2012, 7: 24- 28.
  24. Recommendations for the diagnosis and intensive therapy of the syndrome of disseminated intravascular coagulation in viral lung disease. Ed. prof. Vorobyova P.A. and prof. Elykomova V.A. M .: Moscow City Society of Therapists; 2020.
  25. Terentyeva N.N., Popova M.A. Assessment of the state of endothelial dysfunction in combination with coronary heart disease and chronic obstructive pulmonary disease. Clinical medicine. 2015; 2 (24): 36-39.